White label ELPA - ClinicalTrials.eu

A study to examine how the body processes and removes DC-806 in healthy male volunteers

Not recruiting

1 1 1
Investigated diseases:
- Psoriasis
Investigated drugs:
- Dc-806
- [14C] DC-806
Efficacy and Safety Evaluation of Dazodalibep in Patients with Moderate-to-Severe Systemic Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Not recruiting

3 1
Investigated drugs:
- Dazodalibep
+6
Evaluation of Dazodalibep Efficacy and Safety in Patients with Moderate-to-Severe Sjögren’s Syndrome: A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study

Not recruiting

3 1
Investigated drugs:
- Dazodalibep
+6
A study to evaluate the safety of MK-1403 in healthy men for the treatment of atherosclerosis

Not recruiting

1 1
Investigated diseases:
- Arteriosclerosis
A Phase 3 Randomized Open-Label Study of Sacituzumab Govitecan Versus Physician’s Choice in Recurrent or Persistent Endometrial Cancer Post-Chemotherapy and Immunotherapy

Not recruiting

3 1 1 1
Investigated diseases:
- Endometrial cancer recurrent
Investigated drugs:
- Sacituzumab Govitecan
- Doxorubicin Hydrochloride
+1
A study testing TRIV-509 compared to placebo in adults with moderate to severe atopic dermatitis

Not recruiting

2 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- HUMAN IGG1 BISPECIFIC MONOCLONAL ANTIBODY AGAINST KALLIKREIN-5 AND KALLIKREIN-7
A Study of Leniolisib Safety and Effectiveness for Immune System Problems in Patients with Common Variable Immunodeficiency

Not recruiting

2 1 1
Investigated drugs:
- Leniolisib Phosphate
A Study Comparing Two Forms of Ocrelizumab Given Under the Skin in Patients with Multiple Sclerosis

Not recruiting

2 1 1 1
Investigated diseases:
- Multiple sclerosis
Investigated drugs:
- Ocrelizumab
A Study of Raludotatug Deruxtecan for People with Gastrointestinal Cancers to Evaluate Safety and Effectiveness

Not recruiting

4 1 1
Investigated drugs:
- Raludotatug Deruxtecan
A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer’s disease dementia

Not recruiting

2 1
Investigated drugs:
- Mk-1167

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies